Candel Therapeutics Inc Share Price Today: Live Updates & Key Insights
Candel Therapeutics Inc share price today is $9.58, up -3.04%. The stock opened at $9.78 against the previous close of $9.86, with an intraday high of $9.84 and low of $9.46.
Candel Therapeutics Inc Share Price Chart
Candel Therapeutics Inc
Candel Therapeutics Inc Share Price Performance
Candel Therapeutics Inc Institutional Holdings
Candel Therapeutics Inc Market Status
Candel Therapeutics Inc Fundamentals
Market Cap 722.44 M
PB Ratio 3.2921
PE Ratio 0.0
Enterprise Value 576.88 M
Total Assets 125.20 M
Volume 1012021
Candel Therapeutics Inc Company Financials
About Candel Therapeutics Inc & investment objective
Company Information Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer patients. It develops CAN-2409, which is in Phase 2a clinical trials for the treatment of prostate cancer; and Phase 2a clinical trials for the treatment of non-small cell lung cancer (NSCLC). The company is also developing CAN-3110, which is in Phase Ib clinical trials for the treatment of recurrent high-grade glioma. In addition, it develops the enLIGHTEN Discovery Platform, a systematic, iterative herpes simplex virus based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapy candidates for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts.
Organisation Biotechnology
Employees 55
Industry Biotechnology
CEO Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Candel Therapeutics Inc FAQs
What is the share price of Candel Therapeutics Inc today?
The current share price of Candel Therapeutics Inc is $9.58.
Can I buy Candel Therapeutics Inc shares in India?
Yes, Indian investors can buy Candel Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Candel Therapeutics Inc shares in India?
You can easily invest in Candel Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Candel Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Candel Therapeutics Inc.
Can I buy fractional shares of Candel Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Candel Therapeutics Inc?
Candel Therapeutics Inc has a market cap of $722.44 M.
In which sector does Candel Therapeutics Inc belong?
Candel Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Candel Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Candel Therapeutics Inc?
The PE ratio of Candel Therapeutics Inc is N/A and the PB ratio is 3.29.